Sonoma Pharmaceuticals (NASDAQ: SNOA) reported Q3 EPS of ($0.48), $0.43 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $4.3 million versus the consensus estimate of $5.24 million.

For earnings history and earnings-related data on Sonoma Pharmaceuticals (SNOA) click here.